The 12-Month Price Target For Acelyrin Inc (NASDAQ:SLRN) Is Now 15.

In last trading session, Acelyrin Inc (NASDAQ:SLRN) saw 2.47 million shares changing hands with its beta currently measuring 1.86. Company’s recent per share price level of $2.17 trading at $0.02 or 0.93% at ring of the bell on the day assigns it a market valuation of $218.52M. That closing price of SLRN’s stock is at a discount of -309.68% from its 52-week high price of $8.89 and is indicating a premium of 14.75% from its 52-week low price of $1.85.

For Acelyrin Inc (SLRN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 14 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 9 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.73 in the current quarter.

Acelyrin Inc (NASDAQ:SLRN) trade information

Upright in the green during last session for gaining 0.93%, in the last five days SLRN remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $2.17 price level, adding 1.36% to its value on the day. Acelyrin Inc’s shares saw a change of -30.89% in year-to-date performance and have moved 8.50% in past 5-day. Acelyrin Inc (NASDAQ:SLRN) showed a performance of 9.05% in past 30-days.

Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 85.53% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would drop -591.24% in reaching the projected high whereas dropping to the targeted low would mean a loss of -591.24% for stock’s current value.

In 2025, company’s earnings growth rate is likely to be around 53.73% while estimates for its earnings growth in next 5 years are of 27.40%.

Acelyrin Inc (NASDAQ:SLRN)’s Major holders

AYURMAYA CAPITAL MANAGEMENT COMPANY, LP is the top institutional holder at SLRN for having 9.33 million shares of worth $41.17 million. And as of 2024-06-30, it was holding 9.4136 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.74 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.7835 of outstanding shares, having a total worth of $20.92 million.